Active Shortage Injection Gastroenterology
Amino Acid Injection · 2,099 days since initial FDA posting
Brand: TRAVASOL
FDA lists Amino Acid Injection as Active Shortage (Baxter Healthcare).
Availability on file: Limited Availability
Amino Acid Injection: Active Shortage
Limited Availability Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Amino Acid Injection
- Manufacturer
- Baxter Healthcare
- Dosage Form
- Injection
- Presentation
- Travasol, Injection, 2.07 g/100 mL; 1.15 g/100 mL; 1.03 g/100 mL; 480 mg/100 mL; 600 mg/100 mL; 730 mg/100 mL; 580 mg/100 mL; 400 mg/100 mL; 560 mg/100 mL; 680 mg/100 mL; 500 mg/100 mL; 420 mg/100 mL; 180 mg/100 mL; 40 mg/100 mL; 580 mg/100 mL (NDC 0338-0644-06)
- Package NDC
- 0338-0644-06
Status & Timeline
- Status
- Active Shortage
- Availability
- Limited Availability
- First Reported
- Dec 8, 2020
- Last Updated
- Mar 4, 2026
- Therapeutic Category
- Gastroenterology
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Estimated recovery: March 2026
Nearby, Other Amino Shortage Records
Amino Acid Injection
B. Braun Medical Inc.
Injection
Amino Acid Injection
B. Braun Medical Inc.
Injection
Amino Acid Injection
B. Braun Medical Inc.
Injection
Amino Acid Injection
Otsuka ICU Medical LLC
Injection
Amino Acid Injection
Otsuka ICU Medical LLC
Injection
Amino Acid Injection
Otsuka ICU Medical LLC
Injection
FDA reason on file: Estimated recovery: March 2026. General shortage guidance lives on the tracker hub.